Pharma

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Most Viewed Abstracts



Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Inspire Pharmaceuticals, Inc. announced its intention, subject to market and other conditions, to offer $80 million of its common stock in a registered public offering pursuant to its existing shelf registration statement. Inspire also intends to grant to the underwriter of the offering an option to purchase additional shares of common stock to cover over–allotments, if any. Inspire plans to use the proceeds from the common stock offering for general corporate purposes. Deutsche Bank Securities Inc. is acting as sole underwriter of the offering.

Today in Popular Press...keeping you current

Bayer Team wins the “Deutscher Zukunftspreis” awarded by the German President
BayNews International, 12/03/09

Abbott and the Abbott Fund Honored With Corporate Citizenship Award for International Community Service
Abbott, 12/03/09

Abbotts Ibis Technology Named One of the Top Innovations for 2009 by The Scientist
Abbott, 12/03/09

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Send this Summary to a Colleague

Enter email address